Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
DataTecnica is a private healthcare data science and software company that develops analytics, bioinformatics, and research-enablement platforms for federal health agencies, biotech organizations, and philanthropic research groups. The company focuses on accelerating biomedical research through machine learning, genomics, clinical data analytics, data harmonization, and cloud-based software infrastructure. Its offerings include DataTecnica.AI for biomedical research and data discovery, OmicSynth for genetics- and genomics-based target discovery and due diligence, DIVER for common data element discovery and harmonization, and contributions to CRISPRbrain and other open-science resources. Rather than operating as a traditional therapeutic developer, DataTecnica appears to function primarily as a commercial healthtech and scientific software partner supporting precision medicine, neurology, genomics, and translational research.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on DataTecnica.